Dr Jerry Jenkins Ii, DPM | |
533 Gandy St Ne, Russellville, AL 35653-1965 | |
(256) 331-3338 | |
(256) 331-2890 |
Full Name | Dr Jerry Jenkins Ii |
---|---|
Gender | Male |
Speciality | Podiatry |
Experience | 26 Years |
Location | 533 Gandy St Ne, Russellville, Alabama |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831184688 | NPI | - | NPPES |
DPM221 | Medicaid | AL | |
480029801 | Other | AL | RAILROAD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | M221 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jerry Jenkins Ii, DPM Po Box 1412, Russellville, AL 35653-3212 Ph: (256) 331-3338 | Dr Jerry Jenkins Ii, DPM 533 Gandy St Ne, Russellville, AL 35653-1965 Ph: (256) 331-3338 |
News Archive
A new study looking at nearly three decades of data from some 54,000 people has determined that the overall prevalence of chronic kidney disease (CKD) for several racial/ethnic and socioeconomic groups in the United States has stabilized in recent years, except Mexican Americans.
Researchers at the Cedars-Sinai Heart Institute have found in animals that infusing cardiac-derived stem cells with micro-size particles of iron and then using a magnet to guide those stem cells to the area of the heart damaged in a heart attack boosts the heart's retention of those cells and could increase the therapeutic benefit of stem cell therapy for heart disease.
A USC study that tracked Southern California children over a 20-year period has found they now have significantly fewer respiratory symptoms as a result of improved air quality.
Low-dose growth hormone treatment reduced abdominal fat deposits and improved blood pressure and triglyceride levels in a group of patients with HIV lipodystrophy, a condition involving the redistribution of fat and other metabolic changes in patients receiving combination drug therapy for HIV infection.
ClinTec International, a global Clinical Research Organisation ("CRO") announces financial and strategic partnership with Elephant Capital plc., a London AIM market listed private equity firm. With an investment of £8 Million GBP, Elephant has acquired a significant minority stake in ClinTec.
› Verified 5 days ago